"I love Glucocorticoid Receptor Antagonist Development | Corcept Therapeutics"

2022-05-16 18:39:45

Skip to contentMain MenuContact UsAboutShow submenuAbout CorceptExecutive TeamBoard of DirectorsEducational GrantsContact UsProductShow submenuKorlym® for Cushing SyndromeMedical Information RequestPatientsResearch & PipelineShow submenuCortisol ModulationCortisol Modulation Therapeutic PlatformPipeline and Clinical TrialsPublicationsInvestigator-Initiated StudiesCompassionate UseInvestorsShow submenuInvestors OverviewPress ReleasesEventsCorporate GovernanceAnalyst CoverageStock InformationSEC FilingsCareersShow submenuWorking at CorceptBenefitsTestimonialsCurrent OpportunitiesPioneering the discovery and development of cortisol modulatorsDeveloping cortisol modulators for a broad range of serious diseases, including endocrine, metabolic, oncologic, and psychiatric disordersScroll DownCommitment toScienceWe lead the field in the research and development of selective glucocorticoid receptor (GR) antagonists.Impact of excess cortisol and understanding GR antagonismLearn MoreResearch & PipelineLearn MoreCommitment toPatientsWe are committed to developing novel medications for patients suffering from diseases driven by cortisol dysregulation.Learn MoreCommitment toCultureWe foster a diverse and collaborative environment focused on developing novel therapies that help treat people with serious unmet medical needs.Learn MoreAboutExecutive TeamBoard of DirectorsEducational GrantsContact UsProductKorlym for Cushing SyndromeMedical Information RequestPatientsResearch & PipelineCortisol ModulationCortisol Modulation Therapeutic PlatformPipeline and Clinical TrialsPublicationsInvestigator-Initiated StudiesCompassionate UseInvestorsInvestors OverviewPress ReleasesEventsCorporate GovernanceAnalyst CoverageStock InformationSEC FilingsCareersBenefitsTestimonialsCurrent Opportunities©2022 CorceptPrivacy PolicyTerms of UseSite MapWe use cookies to evaluate and improve your user experience on our website, to analyze our website traffic, and for advertising purposes. To learn more about how we use cookies, and how to change your cookie settings, please visit our Privacy Policy. By continuing to use our site you consent to our use of cookies.Acknowledged